|
Statements of Cash Flows (USD $)
|
6 Months Ended |
|
Feb. 28, 2014
|
Feb. 28, 2013
|
| Operating activities: |
|
|
| Net loss |
$ (817,915) |
$ (100,666) |
| Net gain from discontinued operations |
(95,528) |
|
| Net loss from continuing operations |
(913,443) |
(100,673) |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Depreciation and amortization |
11,493 |
180 |
| Loss on disposal of property and equipment |
28,748 |
|
| Stock based compensation |
91,163 |
|
| Amortization of discount on notes payable and warrants |
18,021 |
|
| Loss on conversion of notes payable - related parties |
93,578 |
10,241 |
| Issuance of stock and warrants for fees |
302,659 |
|
| Changes in operating assets and liabilities: |
|
|
| Accounts receivable |
(144,229) |
|
| Prepaid expenses and other current assets |
2,286 |
4,058 |
| Accounts payable and other accrued expenses |
17,365 |
26,209 |
| Accrued interest payable - related parties |
(60,983) |
7,278 |
| Accrued interest payable |
136,061 |
4,959 |
| Net operating cash flows - continuing operations |
(462,281) |
(47,748) |
| Net operating cash flows - discontinued operations |
95,528 |
|
| Net cash used in operating activities |
(366,753) |
(47,748) |
| Investing activities: |
|
|
| Purchase of property and equipment |
(878) |
|
| Cash acquired with Amian Health Services assets |
8,646 |
|
| Acquisition of Amian Health Services assets |
(75,000) |
|
| Acquisition of Angels subsidiary |
|
|
| Net cash used in investing activities |
(67,232) |
|
| Financing activities: |
|
|
| Proceeds from issuance of convertible notes |
525,000 |
|
| Proceeds from issuance of notes payable - related parties |
|
20,000 |
| Proceeds from issuance of notes payable |
358,848 |
|
| Proceeds from the issuance of common stock |
10,000 |
40,000 |
| Repayment of notes payable |
(300,263) |
(4,067) |
| Repayment of notes payable - related parties |
(4,600) |
(10,044) |
| Repayment of convertible notes payable |
(109,206) |
|
| Net cash provided by financing activities |
479,779 |
45,889 |
| Net increase (decrease) in cash and cash equivalents |
45,794 |
(1,859) |
| Cash and cash equivalents, beginning of period |
39,456 |
1,931 |
| Cash and cash equivalents, end of period |
$ 85,250 |
$ 39,456 |